Moving Spatially Resolved Multiplexed Protein Profiling toward Clinical Oncology

Maryam Pourmaleki1,2,3, Nicholas D Socci4,5, Travis J Hollmann6

  • 1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.

Cancer Discovery
|April 3, 2023
PubMed

Insights

Personalized cancer therapies need better diagnostics. Multiplexed antibody imaging offers a new way to analyze single cells in tumors for more precise treatment.

Area of Science:

  • Oncology
  • Pathology
  • Biotechnology

Background:

  • Cancer therapy is shifting towards personalized treatments targeting specific tumor alterations.
  • Current diagnostic pathology methods need to be quantitative and biospecimen-friendly to support this shift.

Purpose of the Study:

  • To introduce novel multiplexed antibody-based imaging technologies for cancer diagnostics.
  • To highlight the potential of these technologies in clinical oncology.

Main Methods:

  • Utilizing multiplexed antibody-based imaging.
  • Measuring single-cell protein expression in intact tumor sections.
  • Analyzing over 60 proteins simultaneously.

Main Results:

  • Demonstrated the capability of multiplexed antibody imaging to quantify protein expression at the single-cell level.
  • Showcased the application of this technology on intact tumor tissues, preserving biospecimen integrity.

Conclusions:

  • Multiplexed antibody imaging is a promising diagnostic approach for personalized cancer therapy.
  • This technology can provide quantitative, detailed insights into tumor biology for clinical oncology.